BET Protein Inhibition for Pulmonary Arterial Hypertension: A Pilot Clinical Trial

Am J Respir Crit Care Med. 2022 Jun 1;205(11):1357-1360. doi: 10.1164/rccm.202109-2182LE.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Nuclear Proteins
  • Pulmonary Arterial Hypertension*

Substances

  • Nuclear Proteins

Associated data

  • ClinicalTrials.gov/NCT03655704